Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HRG2005 in moderate to severe COPD
NCT06035393Phase 2Terminated
- Sponsor
- Hengrui
- Start
- Jan 2024
- Primary completion
- Feb 2025
- Countries
- 1
01
Overview
A Phase 2 trial of HRG2005 in chronic obstructive pulmonary disease (COPD), sponsored by Hengrui. Started Jan 2024; status: terminated.
02
Drugs
HRG2005
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT06035393.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06035393.